
"Asthma Drug Linked to Suicides and Hallucinations: FDA's Warning Ignored"
The FDA issued a stark warning about the asthma and allergy drug Singulair's potential to cause aggression, agitation, and suicidal thoughts, primarily affecting children. Despite the warning, the drug was still prescribed to 12 million people in the US in 2022, raising concerns about the FDA's approach to addressing troubling side effects from long-approved medicines. Reports of psychiatric problems linked to the drug have surfaced, but the FDA's monitoring system relies on drugmakers to report issues, and the full scale of the problem remains unclear. Researchers and affected families are calling for more proactive measures to educate doctors and patients about the drug's risks, especially for children.

